샘플 요청 목록

 카트 문의
시장보고서
상품코드
1813837

스마트 흡입기 시장 규모, 점유율, 동향 분석 보고서 : 유형별, 적응증별, 유통 채널별, 최종 용도별, 지역별, 부문별 예측(2025-2033년)

Smart Inhalers Market Size, Share & Trends Analysis Report By Type (Dry Powdered Inhalers, Metered Dose Inhalers), By Indication (Asthma, Pulmonary Disease), By Distribution Channel, By End Use, By Region, And Segment Forecasts, 2025 - 2033
발행일: | 리서치사: Grand View Research | 페이지 정보: 영문 100 Pages | 배송안내 : 2-10일 (영업일 기준)

    
    
    




※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

스마트 흡입기 시장 요약

세계 스마트 흡입기 시장 규모는 2024년 184억 달러로 추산되며 2033년에는 919억 달러에 달하고, 2025-2033년 연평균 19.6% 성장할 것으로 예측됩니다.

만성 호흡기 질환(Chronic Respiratory Disease, CRD)의 전 세계 유병률 증가, 기술적으로 진보된 제품 시장 개척, 헬스케어 분야에서의 디지털 솔루션 채택 확대가 시장 성장에 기여할 것으로 예측됩니다.

미국 폐협회 추산에 따르면, 2022년에는 성인의 4.6%에 해당하는 1,170만 명이 만성 기관지염, 폐기종 등 COPD 진단을 받은 것으로 보고되고 있습니다. 또한 WHO는 COPD, 폐암, 결핵 등 치명적일 수 있는 호흡기 질환이 2030년까지 전 세계 사망자 중 약 5명 중 1명을 차지할 것으로 추정하고 있습니다.

스마트 흡입기 개발에 대한 관심이 높아지고 주요 시장 기업의 연구 개발 노력이 증가함에 따라 스마트 흡입기에 대한 수요가 증가하고 있습니다. 또한, 약물의 효과와 천식 및 COPD 관리를 강화하기 위해 디지털 기술을 제품에 접목하는 기업이 늘고 있습니다. 예를 들어, 2022년 4월 시장 기업인 Aptar Pharma는 기존 정량 흡입기를 스마트 흡입기로 전환하는 만성 호흡기 디지털 e-헬스 솔루션인 HeroTracker Sense를 발표했습니다.

또한, 환자의 치료 순응도 및 증상 조절 지원 등 스마트 흡입기 도입의 이점을 강조하는 다양한 연구도 시장 성장에 기여하고 있습니다. 예를 들어, 2020년 클리블랜드 클리닉의 조사에 따르면, 프로펠러의 스마트 흡입기를 사용한 COPD 환자의 입원 위험이 눈에 띄게 감소하고, 전년 대비 내원 건수가 35% 가까이 감소한 것으로 나타났습니다.

또한, 디지털 헬스 기술과 커넥티드 디바이스의 도입으로 환자의 순응도 향상, 원격 모니터링, 맞춤 치료 계획이 가능해졌습니다. 블루투스와 센서 기반 기술의 통합을 통해 의료진은 흡입기 사용량을 추적하고 치료 결과를 최적화할 수 있습니다. 정부의 지원책, 질병 관리에 대한 인식 증가, 제약회사와 하이테크 기업의 협력 관계는 시장 확대를 더욱 가속화하고 있습니다. 또한, 가치 기반 의료로의 전환은 스마트 흡입기의 채택을 촉진하고 있습니다.

목차

제1장 조사 방법과 범위

제2장 주요 요약

제3장 스마트 흡입기 시장 변수, 동향, 범위

  • 시장 계통 전망
    • 상위 시장 전망
    • 관련/보조 시장 전망
  • 업계 분석
    • 사용자 시점 분석
    • 주요 최종사용자
  • 테크놀러지 전망
  • 규제 프레임워크
  • 시장 역학
    • 시장 성장 촉진요인 분석
    • 시장 성장 억제요인 분석
    • 업계 과제와 기회 분석
  • 스마트 흡입기 시장 분석 툴
    • Porter's Five Forces 분석
    • PESTEL 분석

제4장 스마트 흡입기 시장 : 유형 추정 및 동향 분석

  • 정의와 범위
  • 유형 시장 점유율 분석, 2024년 및 2033년
  • 부문 대시보드
  • 스마트 흡입기 시장 : 유형별, 2021-2033년
    • 건식 분말 흡입기(DPI)
    • 정량 분무 흡입기(MDI)

제5장 스마트 흡입기 시장 : 적응증 추정 및 동향 분석

  • 정의와 범위
  • 적응증 시장 점유율 분석, 2024년 및 2033년
  • 부문 대시보드
  • 스마트 흡입기 시장 : 적응증별, 2021-2033년
    • 천식
    • 만성폐쇄성폐질환(COPD)
    • 기타

제6장 스마트 흡입기 시장 : 유통 채널 추정 및 동향 분석

  • 정의와 범위
  • 유통 채널 시장 점유율 분석, 2024년 및 2033년
  • 부문 대시보드
  • 스마트 흡입기 시장 : 유통 채널별, 2021-2033년
    • 병원 약국
    • 소매 약국
    • 온라인 약국

제7장 스마트 흡입기 시장 : 최종 용도 추정 및 동향 분석

  • 정의와 범위
  • 최종 용도 시장 점유율 분석, 2024년 및 2033년
  • 부문 대시보드
  • 스마트 흡입기 시장 : 최종 용도별, 2021-2033년
    • 병원
    • 홈케어
    • 기타

제8장 스마트 흡입기 시장 : 국, 유형, 적응증, 유통 채널, 최종 용도 지역별 추정 및 동향 분석

  • 정의와 범위
  • 지역별 시장 점유율 분석, 2024년 및 2033년
  • 지역 시장 대시보드
  • 지역 시장 스냅숏
  • SWOT 분석
    • 북미
    • 유럽
    • 아시아태평양
    • 라틴아메리카
    • 중동 및 아프리카
  • 북미
    • 미국
    • 캐나다
    • 멕시코
  • 유럽
    • 영국
    • 독일
    • 프랑스
    • 이탈리아
    • 스페인
    • 스웨덴
    • 덴마크
    • 노르웨이
  • 아시아태평양
    • 중국
    • 일본
    • 인도
    • 한국
    • 호주
    • 태국
  • 라틴아메리카
    • 브라질
    • 아르헨티나
  • 중동 및 아프리카
    • 남아프리카공화국
    • 사우디아라비아
    • 아랍에미리트(UAE)
    • 쿠웨이트

제9장 경쟁 구도

  • 주요 시장 진출기업의 최근 동향과 영향 분석
  • 기업 분류
  • 기업의 시장 점유율 분석, 2024년(%)
  • 기업 히트맵 분석
  • 전략 매핑
    • 확대
    • 인수합병(M&A)
    • 파트너십 및 협업
    • 신제품 발매
    • 연구개발
  • 기업 개요
    • Presspart Verwaltungs GmbH.
    • Personal Air Quality Systems Pvt Ltd
    • COHERO Health Inc.(AptarGroup, Inc.)
    • Cognita Labs
    • Adherium
    • Amiko Digital Health Limited.
    • Teva Pharmaceuticals Industries Ltd.
    • Propeller Health(ResMed)
    • Novartis AG
    • Pneuma Respiratory Inc.
    • 3M
    • AireHealth, Inc.
    • FindAir Sp. z oo
LSH 25.09.25

Smart Inhalers Market Summary

The global smart inhalers market size was estimated at USD 18.4 billion in 2024 and is projected to reach USD 91.9 billion by 2033, growing at a CAGR of 19.6% from 2025 to 2033. The rising prevalence of chronic respiratory diseases (CRDs) globally, the development of technologically advanced products, and the growing adoption of digital solutions in the healthcare sector are expected to contribute to the market's growth.

According to estimates from the American Lung Association, in 2022, 11.7 million people, or 4.6% of adults, reported a diagnosis of COPD, including chronic bronchitis and emphysema. In addition, the WHO estimates that potentially fatal respiratory diseases, including COPD, lung cancer, and tuberculosis, will account for about one in five deaths worldwide by 2030.

The increasing focus on developing smart inhalers and a rise in initiatives by key market players for R&D efforts drive the demand for smart inhalers. In addition, more companies are integrating digital technologies into their product offerings to enhance medication effectiveness and the management of asthma and COPD. For instance, in April 2022, Aptar Pharma, a market player, introduced HeroTracker Sense, a chronic respiratory digital e-health solution that converts a conventional metered dose inhaler into a smart inhaler.

Moreover, various research studies highlighting the benefits of adopting smart inhalers, such as assisting patients in treatment adherence and controlling symptoms, also contribute to the market growth. For instance, a 2020 Cleveland Clinic study discovered that patients with COPD using the Propeller company's smart inhalers had a noticeably lower risk of being admitted to the hospital, with a nearly 35% drop in visits compared to the prior year.

Furthermore, increasing adoption of digital health technologies and connected devices is enabling better patient adherence, remote monitoring, and personalized treatment plans. Integration of Bluetooth and sensor-based technologies allows healthcare providers to track inhaler usage and optimize therapy outcomes. Supportive government initiatives, growing awareness about disease management, and collaborations between pharmaceutical companies and tech firms are further accelerating market expansion. In addition, the shift toward value-based care is encouraging the adoption of smart inhalers.

Global Smart Inhalers Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global smart inhalers market report based on type, indication, distribution channel, end use, and region.

  • Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Dry Powdered Inhalers (DPIs)
  • Metered Dose Inhalers (MDIs)
  • Indication Outlook (Revenue, USD Million, 2021 - 2033)
  • Asthma
  • COPD
  • Others
  • Distribution Channel Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • End Use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals
  • Homecare Settings
  • Others
  • Regional Outlook (Revenue, USD Million, 2021 - 2033)
  • North America
    • U.S.
    • Canada
    • Mexico
  • Europe
    • UK
    • Germany
    • France
    • Italy
    • Spain
    • Sweden
    • Denmark
    • Norway
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • South Korea
    • Thailand
  • Latin America
    • Brazil
    • Argentina
  • Middle East and Africa
    • Saudi Arabia
    • South Africa
    • UAE
    • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
  • 1.4. Information Procurement
    • 1.4.1. Purchased Database
    • 1.4.2. GVR's Internal Database
  • 1.5. Details of primary research
  • 1.6. Market Formulation & Validation
  • 1.7. Model Details
    • 1.7.1. Commodity flow analysis (Model 1)
      • 1.7.1.1. Approach 1: Commodity flow approach
    • 1.7.2. Volume price analysis (Model 2)
      • 1.7.2.1. Approach 2: Volume price analysis
  • 1.8. Research Scope and Assumptions
    • 1.8.1. List of Secondary Sources
    • 1.8.2. List of Primary Sources
    • 1.8.3. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
    • 2.2.1. Type Outlook
    • 2.2.2. Indication Outlook
    • 2.2.3. Distribution Channel Outlook
    • 2.2.4. End Use Outlook
    • 2.2.5. Regional Outlook
  • 2.3. Competitive Insights

Chapter 3. Smart Inhalers Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
    • 3.1.1. Parent Market Outlook
    • 3.1.2. Related/Ancillary Market Outlook
  • 3.2. Industry Analysis
    • 3.2.1. User Perspective Analysis
    • 3.2.2. Key End Users
  • 3.3. Technology Outlook
  • 3.4. Regulatory Framework
  • 3.5. Market Dynamics
    • 3.5.1. Market Drivers Analysis
      • 3.5.1.1. Rising prevalence of respiratory diseases
      • 3.5.1.2. Development of technologically advanced solutions
      • 3.5.1.3. Growing adoption of digital health technologies
    • 3.5.2. Market Restraints Analysis
      • 3.5.2.1. Higher cost than traditional inhalers
    • 3.5.3. Industry Challenges and Opportunity Analysis
  • 3.6. Smart Inhalers Market Analysis Tools
    • 3.6.1. Porter's Analysis
      • 3.6.1.1. Bargaining power of the suppliers
      • 3.6.1.2. Bargaining power of the buyers
      • 3.6.1.3. Threats of substitution
      • 3.6.1.4. Threats from new entrants
      • 3.6.1.5. Competitive rivalry
    • 3.6.2. PESTEL Analysis
      • 3.6.2.1. Political landscape
      • 3.6.2.2. Economic and Social landscape
      • 3.6.2.3. Technological landscape
      • 3.6.2.4. Environmental landscape
      • 3.6.2.5. Legal landscape

Chapter 4. Smart Inhalers Market: Type Estimates & Trend Analysis

  • 4.1. Definition and Scope
  • 4.2. Type Market Share Analysis, 2024 & 2033
  • 4.3. Segment Dashboard
  • 4.4. Smart Inhalers Market: By Type, 2021 to 2033
    • 4.4.1. Dry Powdered Inhalers (DPIs)
      • 4.4.1.1. Dry Powdered Inhalers (DPIs) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 4.4.2. Metered Dose Inhalers (MDIs)
      • 4.4.2.1. Metered Dose Inhalers (MDIs) Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)

Chapter 5. Smart Inhalers Market: Indication Estimates & Trend Analysis

  • 5.1. Definition and Scope
  • 5.2. Indication Market Share Analysis, 2024 & 2033
  • 5.3. Segment Dashboard
  • 5.4. Smart Inhalers Market: By Indication, 2021 to 2033
    • 5.4.1. Asthma
      • 5.4.1.1. Asthma Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 5.4.2. COPD
      • 5.4.2.1. COPD Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 5.4.3. Others
      • 5.4.3.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)

Chapter 6. Smart Inhalers Market: Distribution Channel Estimates& Trend Analysis

  • 6.1. Definition and Scope
  • 6.2. Distribution Channel Market Share Analysis, 2024 & 2033
  • 6.3. Segment Dashboard
  • 6.4. Smart Inhalers Market: By Distribution Channel, 2021 to 2033
    • 6.4.1. Hospital Pharmacies
      • 6.4.1.1. Hospital Pharmacies Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 6.4.2. Retail Pharmacies
      • 6.4.2.1. Retail Pharmacies Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 6.4.3. Online Pharmacies
      • 6.4.3.1. Online Pharmacies Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)

Chapter 7. Smart Inhalers Market: End Use Estimates& Trend Analysis

  • 7.1. Definition and Scope
  • 7.2. End Use Market Share Analysis, 2024 & 2033
  • 7.3. Segment Dashboard
  • 7.4. Smart Inhalers Market: By End Use, 2021 to 2033
    • 7.4.1. Hospital
      • 7.4.1.1. Hospital Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 7.4.2. Homecare Settings
      • 7.4.2.1. Homecare Settings Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 7.4.3. Others
      • 7.4.3.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Billion)

Chapter 8. Smart Inhalers Market: Regional Estimates & Trend Analysis by Country, Type, Indication, Distribution Channel, End Use

  • 8.1. Definition and Scope
  • 8.2. Regional Market Share Analysis, 2024 & 2033
  • 8.3. Regional Market Dashboard
  • 8.4. Regional Market Snapshot
  • 8.5. SWOT Analysis
    • 8.5.1. North America
    • 8.5.2. Europe
    • 8.5.3. Asia Pacific
    • 8.5.4. Latin America
    • 8.5.5. Middle East & Africa
  • 8.6. Smart Inhalers Market Share, By Region, 2024 & 2033 (USD Billion)
  • 8.7. North America
    • 8.7.1. North America Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.7.2. U.S.
      • 8.7.2.1. Key Country Dynamics
      • 8.7.2.2. Regulatory Landscape/Reimbursement Scenario
      • 8.7.2.3. Competitive Insights
      • 8.7.2.4. U.S. Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.7.3. Canada
      • 8.7.3.1. Key Country Dynamics
      • 8.7.3.2. Regulatory Landscape/Reimbursement Scenario
      • 8.7.3.3. Competitive Insights
      • 8.7.3.4. Canada Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.7.4. Mexico
      • 8.7.4.1. Key Country Dynamics
      • 8.7.4.2. Regulatory Landscape/Reimbursement Scenario
      • 8.7.4.3. Competitive Insights
      • 8.7.4.4. Mexico Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 8.8. Europe
    • 8.8.1. Europe Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.8.2. UK
      • 8.8.2.1. Key Country Dynamics
      • 8.8.2.2. Regulatory Landscape/Reimbursement Scenario
      • 8.8.2.3. Competitive Insights
      • 8.8.2.4. UK Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.8.3. Germany
      • 8.8.3.1. Key Country Dynamics
      • 8.8.3.2. Regulatory Landscape/Reimbursement Scenario
      • 8.8.3.3. Competitive Insights
      • 8.8.3.4. Germany Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.8.4. France
      • 8.8.4.1. Key Country Dynamics
      • 8.8.4.2. Regulatory Landscape/Reimbursement Scenario
      • 8.8.4.3. Competitive Insights
      • 8.8.4.4. France Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.8.5. Italy
      • 8.8.5.1. Key Country Dynamics
      • 8.8.5.2. Regulatory Landscape/Reimbursement Scenario
      • 8.8.5.3. Competitive Insights
      • 8.8.5.4. Italy Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.8.6. Spain
      • 8.8.6.1. Key Country Dynamics
      • 8.8.6.2. Regulatory Landscape/Reimbursement Scenario
      • 8.8.6.3. Competitive Insights
      • 8.8.6.4. Spain Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.8.7. Sweden
      • 8.8.7.1. Key Country Dynamics
      • 8.8.7.2. Regulatory Landscape/Reimbursement Scenario
      • 8.8.7.3. Competitive Insights
      • 8.8.7.4. Sweden Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.8.8. Denmark
      • 8.8.8.1. Key Country Dynamics
      • 8.8.8.2. Regulatory Landscape/Reimbursement Scenario
      • 8.8.8.3. Competitive Insights
      • 8.8.8.4. Denmark Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.8.9. Norway
      • 8.8.9.1. Key Country Dynamics
      • 8.8.9.2. Regulatory Landscape/Reimbursement Scenario
      • 8.8.9.3. Competitive Insights
      • 8.8.9.4. Norway Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 8.9. Asia Pacific
    • 8.9.1. Asia Pacific Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.9.2. China
      • 8.9.2.1. Key Country Dynamics
      • 8.9.2.2. Regulatory Landscape/Reimbursement Scenario
      • 8.9.2.3. Competitive Insights
      • 8.9.2.4. China Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.9.3. Japan
      • 8.9.3.1. Key Country Dynamics
      • 8.9.3.2. Regulatory Landscape/Reimbursement Scenario
      • 8.9.3.3. Competitive Insights
      • 8.9.3.4. Japan Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.9.4. India
      • 8.9.4.1. Key Country Dynamics
      • 8.9.4.2. Regulatory Landscape/Reimbursement Scenario
      • 8.9.4.3. Competitive Insights
      • 8.9.4.4. India Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.9.5. South Korea
      • 8.9.5.1. Key Country Dynamics
      • 8.9.5.2. Regulatory Landscape/Reimbursement Scenario
      • 8.9.5.3. Competitive Insights
      • 8.9.5.4. South Korea Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.9.6. Australia
      • 8.9.6.1. Key Country Dynamics
      • 8.9.6.2. Regulatory Landscape/Reimbursement Scenario
      • 8.9.6.3. Competitive Insights
      • 8.9.6.4. Australia Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.9.7. Thailand
      • 8.9.7.1. Key Country Dynamics
      • 8.9.7.2. Regulatory Landscape/Reimbursement Scenario
      • 8.9.7.3. Competitive Insights
      • 8.9.7.4. Thailand Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 8.10. Latin America
    • 8.10.1. Latin America Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.10.2. Brazil
      • 8.10.2.1. Key Country Dynamics
      • 8.10.2.2. Regulatory Landscape/Reimbursement Scenario
      • 8.10.2.3. Competitive Insights
      • 8.10.2.4. Brazil Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.10.3. Argentina
      • 8.10.3.1. Key Country Dynamics
      • 8.10.3.2. Regulatory Landscape/Reimbursement Scenario
      • 8.10.3.3. Competitive Insights
      • 8.10.3.4. Argentina Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
  • 8.11. Middle East and Africa
    • 8.11.1. Middle East and Africa Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.11.2. South Africa
      • 8.11.2.1. Key Country Dynamics
      • 8.11.2.2. Regulatory Landscape/Reimbursement Scenario
      • 8.11.2.3. Competitive Insights
      • 8.11.2.4. South Africa Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.11.3. Saudi Arabia
      • 8.11.3.1. Key Country Dynamics
      • 8.11.3.2. Regulatory Landscape/Reimbursement Scenario
      • 8.11.3.3. Competitive Insights
      • 8.11.3.4. Saudi Arabia Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.11.4. UAE
      • 8.11.4.1. Key Country Dynamics
      • 8.11.4.2. Regulatory Landscape/Reimbursement Scenario
      • 8.11.4.3. Competitive Insights
      • 8.11.4.4. UAE Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Billion)
    • 8.11.5. Kuwait
      • 8.11.5.1. Key Country Dynamics
      • 8.11.5.2. Regulatory Landscape/Reimbursement Scenario
      • 8.11.5.3. Competitive Insights
      • 8.11.5.4. UAE Smart Inhalers Market Estimates and Forecasts, 2021 - 2033 (USD Billion)

Chapter 9. Competitive Landscape

  • 9.1. Recent Developments & Impact Analysis by Key Market Participants
  • 9.2. Company Categorization
  • 9.3. Company Market Share Analysis, 2024 (%)
  • 9.4. Company Heat Map Analysis
  • 9.5. Strategy Mapping
    • 9.5.1. Expansion
    • 9.5.2. Mergers & Acquisition
    • 9.5.3. Partnerships & Collaborations
    • 9.5.4. New Product Launches
    • 9.5.5. Research And Development
  • 9.6. Company Profiles
    • 9.6.1. Presspart Verwaltungs GmbH.
      • 9.6.1.1. Participant's Overview
      • 9.6.1.2. Financial Performance
      • 9.6.1.3. Product Benchmarking
      • 9.6.1.4. Recent Developments
    • 9.6.2. Personal Air Quality Systems Pvt Ltd
      • 9.6.2.1. Participant's Overview
      • 9.6.2.2. Financial Performance
      • 9.6.2.3. Product Benchmarking
      • 9.6.2.4. Recent Developments
    • 9.6.3. COHERO Health Inc. (AptarGroup, Inc.)
      • 9.6.3.1. Participant's Overview
      • 9.6.3.2. Financial Performance
      • 9.6.3.3. Product Benchmarking
      • 9.6.3.4. Recent Developments
    • 9.6.4. Cognita Labs
      • 9.6.4.1. Participant's Overview
      • 9.6.4.2. Financial Performance
      • 9.6.4.3. Product Benchmarking
      • 9.6.4.4. Recent Developments
    • 9.6.5. Adherium
      • 9.6.5.1. Participant's Overview
      • 9.6.5.2. Financial Performance
      • 9.6.5.3. Product Benchmarking
      • 9.6.5.4. Recent Developments
    • 9.6.6. Amiko Digital Health Limited.
      • 9.6.6.1. Participant's Overview
      • 9.6.6.2. Financial Performance
      • 9.6.6.3. Product Benchmarking
      • 9.6.6.4. Recent Developments
    • 9.6.7. Teva Pharmaceuticals Industries Ltd.
      • 9.6.7.1. Participant's Overview
      • 9.6.7.2. Financial Performance
      • 9.6.7.3. Product Benchmarking
      • 9.6.7.4. Recent Developments
    • 9.6.8. Propeller Health (ResMed)
      • 9.6.8.1. Participant's Overview
      • 9.6.8.2. Financial Performance
      • 9.6.8.3. Product Benchmarking
      • 9.6.8.4. Recent Developments
    • 9.6.9. Novartis AG
      • 9.6.9.1. Participant's Overview
      • 9.6.9.2. Financial Performance
      • 9.6.9.3. Product Benchmarking
      • 9.6.9.4. Recent Developments
    • 9.6.10. Pneuma Respiratory Inc.
      • 9.6.10.1. Participant's Overview
      • 9.6.10.2. Financial Performance
      • 9.6.10.3. Product Benchmarking
      • 9.6.10.4. Recent Developments
    • 9.6.11. 3M
      • 9.6.11.1. Participant's Overview
      • 9.6.11.2. Financial Performance
      • 9.6.11.3. Product Benchmarking
      • 9.6.11.4. Recent Developments
    • 9.6.12. AireHealth, Inc.
      • 9.6.12.1. Participant's Overview
      • 9.6.12.2. Financial Performance
      • 9.6.12.3. Product Benchmarking
      • 9.6.12.4. Recent Developments
    • 9.6.13. FindAir Sp. z o.o
      • 9.6.13.1. Participant's Overview
      • 9.6.13.2. Financial Performance
      • 9.6.13.3. Product Benchmarking
      • 9.6.13.4. Recent Developments
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제